Pentraxin-3 predicts functional recovery and 1-year major adverse cardiovascular events after rehabilitation of cardiac surgery patients

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 32, Issue 1, 2012, Pages 17-24

  Ferratini, Maurizio ^a   Ripamonti, Vittorino ^a   Masson, Serge ^b   Grati, Paola ^a   Racca, Vittorio ^a   Cuccovillo, Ivan ^e   Raimondi, Elena ^b   Capomolla, Soccorso ^a   Macchi, Claudio ^a   Coruzzi, Paolo ^a   Vago, Tarcisio ^c   Calvo, Maria ^a   Mantovani, Alberto ^d,e   Latini, Roberto ^b  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

biomarkers; cardiac rehabilitation; cardiac surgery; pentraxin 3

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE; MYOGLOBIN; PENTRAXIN 3; TROPONIN T;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; EXERCISE TOLERANCE; FEMALE; HEART REHABILITATION; HEART SURGERY; HEART VALVE SURGERY; HUMAN; MAJOR ADVERSE CARDIOVASCULAR EVENT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; TRAINING; WALKING;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; ENDOTHELIUM, VASCULAR; EXERCISE TOLERANCE; FEMALE; HUMANS; INFLAMMATION; ITALY; MALE; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SERUM AMYLOID P-COMPONENT; STATISTICS AS TOPIC; STRESS, PHYSIOLOGICAL; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 84855345096     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0b013e31823be0f4     Document Type: Article

References (35)

1. Libby P, Ridker PM, Hansson GK, et al. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129-2138.
2. Lavie CJ, Milani RV, Verma A, et al. C-reactive protein and cardiovascular diseases - is it ready for primetime? Am J Med Sci. 2009;338:486-492.
3. Masson S, Latini R, Milani V, et al. GISSI-HF Investigators. Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial. Circ Heart Fail. 2010;3:65-72.
4. Giallauria F, De Lorenzo A, Pilerci F, et al. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2006;13:625-632. (Pubitemid 44162167)
5. Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM. Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 2009;29:594-599.
6. Guazzi M, Dickstein K, Vicenzi M, Arena R. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis of clinical and prognostic insights. Circ Heart Fail. 2009;2:549-555.
7. Gardner AW, Katzel LI, Sorkin JD, et al. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomised control trial. J Am Geriatric Soc. 2001;49:755-762. (Pubitemid 32652468)
8. Fiorina C, Vizzardi E, Lorusso R, et al. The 6-min walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme. Eur J Cardiothorac Surg. 2007;32:724-729. (Pubitemid 47520666)
9. Cahalin LP, Mathier MA, Semigran MJ, Dec GW, Di Salvo TG. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest. 1996;110:325-332. (Pubitemid 26269255)
10. Enright PL, Sherrill DL. Reference equations for the six-minute walk test in healthy adults. Am J Respir Crit Care Med. 1998;158:1384-1387.
11. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14:270-274. (Pubitemid 29461288)
12. Steffen TM, Hacker TA, Mollinger L. Age and gender-related test performance in community-dwelling elderly people: six-minute walk test, Berg balance scale, timed up and go test and gait speeds. Physical Therapy. 2002;82:128-137. (Pubitemid 34112999)
13. AACVPR/ACCF/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services. J Am Coll Cardiol. 2010;56:1159-1167.
14. Giannuzzi P, Saner H, Bjomstad H, et al. Working group on cardiac rehabilitation and exercise physiology of the European Society of Cardiology: secondary prevention through cardiac rehabilitation. Eur Heart J. 2003;24:1273-1278. (Pubitemid 36834643)
15. Piepoli MF, Corrà U, Benzer W, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17:1-17.
16. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254-261.
17. Peri G, Introna M, Corradi D, et al. PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation. 2000;102:636-641. (Pubitemid 30640663)
18. Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157-183.
19. Vouret-Craviari V, Matteucci C, Peri G, Poli G, Introna M, Mantovani A. Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Infect Immun. 1997;65:1345-1350. (Pubitemid 27146623)
20. Rolph MS, Zimmer S, Bottazzi B, Garlanda C, Mantovani A, Hansson GK. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2002;22(5):e10-e14.
21. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med. 2007;204:793-804. (Pubitemid 46631609)
22. Nebuloni M, Pasqualini F, Zerbi P, et al. PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis. Cardiovasc Pathol. 2011;20:e27-e35.
23. Matsui S, Ishii J, Kitagawa F, et al. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis. 2010;210:220-225.
24. Latini R, Maggioni AP, Peri G, et al. Lipid Assessment Trial Italian Network (LATIN) Investigators. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2004;110:2349-2354. (Pubitemid 39407338)
25. Suzuki S, Takeishi Y, Niizeki T, et al. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J. 2008;155:75-81. (Pubitemid 350234768)
26. Leon AS, Franklin BA, Costa F, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2005;111:369-376.
27. Lavie CJ, Church TS, Milani RV, et al. Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev. 2011;31:137-145
28. Passino C, Severino S, Poletti R, et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol. 2006;47:1835-1839.
29. Jonsdottir S, Andersen KK, Sigurosson AF, Sigurosson SB. The effect of physical training in chronic heart failure. Eur J Heart Fail. 2006;8:97-101. (Pubitemid 43012107)
30. Milani RV, Lavie CJ, Mehra MR. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol. 2004;43:1056-1061. (Pubitemid 38352988)
31. Plüss CE, Karlsson MR, Wallen NH, Billing E, Held C. Effects of an expanded cardiac rehabilitation programme in patients treated for an acute myocardial infarction or a coronary artery by-pass graft operation. Clin Rehabil. 2008;22:306-318. (Pubitemid 351676274)
32. Shuichi T, Satoru S, Takeshi B, et al. Predictors of left ventricular remodeling in patients with acute myocardial infarction participating in cardiac rehabilitation. Circ J. 2004;68:214-219.
33. Gullo JD, Bertotti MM, Silva CC, et al. Hospital mortality of patients with severe traumatic brain injury is associated with serum PTX3 levels. Neurocrit Care. 2011;14:194-199.
34. de Kruif MD, Limper M, Sierhuis K, et al. PTX3 predicts severe disease in febrile patients at the emergency department. J Infect. 2010;60:122-127.
35. Yano Y, Matsuda S, Hatakeyama K, et al. Plasma pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients [published online ahead of print March 4, 2010]. J Gerontol A Biol Sci Med Sci. 2010;65:547-552.